MX2015015079A - Geles de nano-red inyectables para tratamiento de diabetes. - Google Patents
Geles de nano-red inyectables para tratamiento de diabetes.Info
- Publication number
- MX2015015079A MX2015015079A MX2015015079A MX2015015079A MX2015015079A MX 2015015079 A MX2015015079 A MX 2015015079A MX 2015015079 A MX2015015079 A MX 2015015079A MX 2015015079 A MX2015015079 A MX 2015015079A MX 2015015079 A MX2015015079 A MX 2015015079A
- Authority
- MX
- Mexico
- Prior art keywords
- glucose
- insulin
- delivery
- diabetes treatment
- injectable nano
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 239000000499 gel Substances 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 3
- 102000004877 Insulin Human genes 0.000 abstract 3
- 108090001061 Insulin Proteins 0.000 abstract 3
- 239000008103 glucose Substances 0.000 abstract 3
- 229940125396 insulin Drugs 0.000 abstract 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 abstract 1
- 229920002307 Dextran Polymers 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 235000012208 gluconic acid Nutrition 0.000 abstract 1
- 239000000174 gluconic acid Substances 0.000 abstract 1
- 230000003345 hyperglycaemic effect Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 238000007726 management method Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361817752P | 2013-04-30 | 2013-04-30 | |
| US201361864069P | 2013-08-09 | 2013-08-09 | |
| PCT/US2014/035927 WO2014179344A1 (en) | 2013-04-30 | 2014-04-29 | Injectable nano-network gels for diabetes treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015015079A true MX2015015079A (es) | 2016-07-05 |
Family
ID=51843897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015015079A MX2015015079A (es) | 2013-04-30 | 2014-04-29 | Geles de nano-red inyectables para tratamiento de diabetes. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160067190A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2991673A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2016517885A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20160024853A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105813652A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014260024B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015027561A8 (cg-RX-API-DMAC7.html) |
| HK (2) | HK1222546A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2015015079A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2015151135A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014179344A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014153114A1 (en) * | 2013-03-14 | 2014-09-25 | Fred Hutchinson Cancer Research Center | Compositions and methods to modify cells for therapeutic objectives |
| JP2017538728A (ja) * | 2014-12-19 | 2017-12-28 | ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． | イオントフォレシスを用いた生物活性分子の眼内送達 |
| CN104740641B (zh) * | 2015-04-08 | 2019-02-01 | 烟台大学 | 一种糖敏感的缓控释微球组合物及其制备方法 |
| BR112017022535A2 (pt) * | 2015-04-21 | 2018-07-10 | Univ North Carolina State | sistema de liberação de insulina responsivo à glicose usando nanocompósitos sensíveis à hipóxia. |
| CN113730605A (zh) * | 2016-07-21 | 2021-12-03 | 波士顿科学国际有限公司 | 可注射组合物 |
| US11351230B2 (en) | 2016-11-07 | 2022-06-07 | North Carolina State University | Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery |
| WO2018106696A1 (en) * | 2016-12-05 | 2018-06-14 | North Carolina State University | Core-shell microneedle devices and uses thereof |
| CN106668840B (zh) * | 2017-02-10 | 2020-02-14 | 南通大学 | 一种胰岛素控释药物及其制备方法与应用 |
| CN111343970A (zh) * | 2017-09-13 | 2020-06-26 | 北卡罗莱纳州立大学 | 微针贴片局部诱导脂肪组织褐变治疗肥胖症 |
| EP3713594A4 (en) | 2017-11-21 | 2021-11-03 | North Carolina State University | LOADABLE POLYMERIC DEPOT FOR GLUCOSE-TRIGGERED INSULIN DELIVERY WITH ULTRA-FAST REACTION |
| EP3735262A4 (en) * | 2018-01-03 | 2021-09-29 | Penn State Research Foundation | GLUCOSE OXIDASE COMPOSITIONS USED AS AN ANTI-CONVULSIVER IN NEWBORNS |
| CN111195238A (zh) * | 2018-10-31 | 2020-05-26 | 南方医科大学 | 一种用于胰岛素口服递送的聚电解质复合物 |
| WO2020219880A2 (en) * | 2019-04-25 | 2020-10-29 | Massachusetts Institute Of Technology | Cyclodextrin supramolecular scaffolds and uses thereof |
| CN115350267B (zh) * | 2022-07-19 | 2025-01-14 | 深圳大学 | 一种级联催化型纳米治疗剂及其制备方法和应用 |
| CN116474162B (zh) * | 2023-04-28 | 2024-08-16 | 吉林大学 | 一种用于糖尿病慢性创伤修复的自修复水凝胶的制备方法 |
| WO2025024243A1 (en) * | 2023-07-21 | 2025-01-30 | Massachusetts Institute Of Technology | Readily soluble and thermostable glucagon formulations and delivery for mini-dosing and closed-loop prophylactic treatment of hypoglycemia |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| AU3360197A (en) * | 1996-07-01 | 1998-01-21 | Universiteit Utrecht | Hydrolysable hydrogels for controlled release |
| AU2003301064A1 (en) * | 2002-12-17 | 2004-07-14 | Massachusetts Institute Of Technology | Stimuli-responsive systems for controlled drug delivery |
| WO2006088473A2 (en) * | 2004-04-23 | 2006-08-24 | Panduranga Rao Koritala | Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents |
| EP1595534A1 (en) * | 2004-05-13 | 2005-11-16 | Universiteit Utrecht Holding B.V. | Gel composition comprising charged polymers |
| TWI394580B (zh) * | 2008-04-28 | 2013-05-01 | Halozyme Inc | 超快起作用胰島素組成物 |
| US20110189299A1 (en) * | 2008-07-01 | 2011-08-04 | Nitto Denko Corporation | Pharmaceutical composition containing surface-coated microparticles |
-
2014
- 2014-04-29 CN CN201480037463.3A patent/CN105813652A/zh active Pending
- 2014-04-29 HK HK16110684.2A patent/HK1222546A1/zh unknown
- 2014-04-29 JP JP2016511809A patent/JP2016517885A/ja active Pending
- 2014-04-29 HK HK16109650.4A patent/HK1221415A1/zh unknown
- 2014-04-29 BR BR112015027561A patent/BR112015027561A8/pt not_active Application Discontinuation
- 2014-04-29 EP EP14792285.0A patent/EP2991673A4/en not_active Withdrawn
- 2014-04-29 AU AU2014260024A patent/AU2014260024B2/en not_active Ceased
- 2014-04-29 MX MX2015015079A patent/MX2015015079A/es unknown
- 2014-04-29 WO PCT/US2014/035927 patent/WO2014179344A1/en not_active Ceased
- 2014-04-29 KR KR1020157034126A patent/KR20160024853A/ko not_active Withdrawn
- 2014-04-29 US US14/787,652 patent/US20160067190A1/en not_active Abandoned
- 2014-04-29 RU RU2015151135A patent/RU2015151135A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160024853A (ko) | 2016-03-07 |
| EP2991673A1 (en) | 2016-03-09 |
| RU2015151135A (ru) | 2017-06-02 |
| HK1222546A1 (zh) | 2017-07-07 |
| JP2016517885A (ja) | 2016-06-20 |
| EP2991673A4 (en) | 2016-12-21 |
| BR112015027561A8 (pt) | 2019-12-24 |
| US20160067190A1 (en) | 2016-03-10 |
| AU2014260024A1 (en) | 2015-11-19 |
| HK1221415A1 (zh) | 2017-06-02 |
| BR112015027561A2 (pt) | 2017-07-25 |
| CN105813652A (zh) | 2016-07-27 |
| AU2014260024B2 (en) | 2016-09-15 |
| WO2014179344A1 (en) | 2014-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015015079A (es) | Geles de nano-red inyectables para tratamiento de diabetes. | |
| PH12017501910A1 (en) | Glucose-responsive insulin delivery system using hyoxia-sensitive nanocomposites | |
| WO2014093696A3 (en) | Insulin derivatives for diabetes treatment | |
| WO2011163232A3 (en) | Polypeptide electrospun nanofibrils of defined composition | |
| BR112015005878A2 (pt) | nanopartículas terapêuticas compreendendo agente terapêutico e métodos de preparar e usar as mesmas | |
| MX2012001204A (es) | Composiciones de polimero de acido hialuronico modificado y metodos relacionados. | |
| WO2011037607A3 (en) | Semi-closed loop insulin delivery | |
| MX2014009480A (es) | Metodo compartimentado de administracion de acidos nucleicos y composiciones y usos del mismo. | |
| WO2010131916A3 (ko) | siRNA 접합체 및 그 제조방법 | |
| WO2014165490A3 (en) | Compositions of delivery systems for personal care products | |
| WO2013130830A3 (en) | Systems and methods for generating, managing, and sharing prescriptions with digital scripts | |
| WO2014082611A8 (en) | Fibres based on hydrophobized derivatives of hyaluronan, method of their preparation and use, textiles on base thereof and use thereof | |
| BR112013007740A2 (pt) | métodos para processamento de microesferas, microesferas processadas por tais métodos e seus usos | |
| MY181626A (en) | Treatment of diabetes mellitus by long-acting formulations of insulins | |
| NZ715595A (en) | Treatment of disease with poly-n-acetyglucosamine nanofibers | |
| WO2013090523A3 (en) | Methods, systems, and compositions for cell-derived/vesicle-based microrna delivery | |
| CA2816999A1 (en) | Compositions and methods for nanopolymer-based nucleic acid delivery | |
| NZ630385A (en) | Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance | |
| Nakamura et al. | Spiny keratoderma of the palms in an insulin-treated diabetic patient | |
| RS20150784A1 (sr) | Dobijanje kompozitnih diskova hidrogelova polivinil alkohol/grafen sa inkorporisanim nanočesticama srebra | |
| Choi et al. | Super-Tough Hybridgels Comprising of Mesoporous Silica Microrods and Double-Network Polymers for On-Demand Drug Delivery by Mechanical Stimulation | |
| Pochan | Injectable Solid Peptide Hydrogel as Cell Carrier: Effects of Shear Flow on Hydrogel and Cell Payload | |
| UA66429U (ru) | Способ иммобилизации трипсина | |
| Sokolova | Changes in sugar and acid levels in apricots during stirage as affected by treatment with ACM | |
| Yan | Injectable hydrogel as cell carriers: Mechanism of beta-hairpin peptide hydrogel shear thinning, immediate recovery and effects on encapsulated cell payload |